March 2005
Worldwide Biotech;Mar2005, Vol. 17 Issue 3, p1
Trade Publication
Reports on a patent granted by the U.S. to Imugene for its Receptor Mimic Technology through 2020. Importance of the technology to prevent the development of diarrhea in pigs; Ability of the receptor mimic product to bind toxins and bacteria which cause gastrointestinal diseases to mammals; Remarks from Imugene managing director Warwick Lamb on the significance of the patent to the animal industry in the country.


Related Articles

  • The End Of Free Sharing In Insurance. Bakos, Tom; Nowotarski, Mark // National Underwriter / Property & Casualty Risk & Benefits Manag;11/3/2003, Vol. 107 Issue 44, p20 

    Focuses on the patenting of new product innovations in the U.S. insurance industry. Patenting of business method inventions; Protection of the value of new intellectual property created in the business arena; Total number of patents on new insurance products and processes since July 23, 1998.

  • Security first.  // Crain's Cleveland Business;05/19/97, Vol. 18 Issue 20, p17 

    Relates information on the patent which Michael McDonald, director of campus and environment safety at Kent States, received on a device called `Evacuation Assistance Locator.' Description of the device; Who can use the device; Purpose of the device.

  • Patents. Fox, Barry // New Scientist;06/13/98, Vol. 158 Issue 2138, p7 

    Presents recently patented ideas as of June 13, 1998. Aroma-emitting television and computers by Ricoh of Japan; Alternating speeds at which a movie is recorded patented by Robert Weisgerber of New York; Effect of alternating speeds; Toothbrush with variable heads patented by Michael Sotirakis...

  • PATENTS. Fox, Barry // New Scientist;9/29/2001, Vol. 171 Issue 2310, p21 

    Presents products with pending patents as of September 29, 2001. Proposed binoculars with image sensors that send moving pictures to a memory chip; Geneticware's development of an innovative way to keep Internet messages secret; University of Bristol's development of electrodes that could give...

  • ANTECEDENTS AND CONSEQUENCES OF PATENT VALUE: A CONCEPTUAL MODEL OF PRODUCT DEVELOPMENT IMPACT. Malewicki, Debra S.; Sivakumar, K. // AMA Winter Educators' Conference Proceedings;2000, Vol. 11, p214 

    To address this important gap in the literature, this article focuses on the factors governing the perceived value of patents and how such perceptions affect the firm's product development strategies. Our model consists of three sets of variables: the perceived value of patents, the variables...

  • ASK JEFF ABOUT. Sheldon, Jeffrey G. // Inventors' Digest;Jul2014, Vol. 30 Issue 7, p22 

    The article presents an answer to question related to product development and claiming of patent right.

  • II. PENDING MERGERS AND ACQUISITIONS.  // BioWorld Insight;12/2/2013, Vol. 21 Issue 49, p14 

    A table is presented which lists global biotech companies' pending mergers and acquisition as of December 2013 including Imugene Ltd., Perrigo Co. and Theraclone Sciences Inc.

  • Imugene Buys Biolife Science. COLLINS, ALLISON // Mergers & Acquisitions Report;10/28/2013, Vol. 28 Issue 43, p20 

    The article reports on the acquisition of cancer drug developer Biolife Science Qld Ltd. by pharmaceutical company Imugene.

  • New Product Development and the Optimal Duration of Patents. Chien-Fu Chou; Shy, Oz // Southern Economic Journal;Jan91, Vol. 57 Issue 3, p811 

    Economists and policy makers have always argued that the patent system is necessary for a growing economy despite the fact that temporary monopoly rights to innovators imply a distortion of the price system. However, economists have not yet come up with a unified theory to determine the optimal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics